Saturday links: converging costs
Tadas Viskanta
Abnormal Returns
21 hours ago
3 MIN READ
Ride share
- Waymo is rolling out its new Ojai robotaxis. (cnbc.com)
- Josh Brown talks autonomous driving with Andrew Macdonald, President and Chief Operating Officer at Uber ($UBER). (youtube.com)
- Do rideshare customers compare prices? (nber.org)
Transport
- A third of road deaths are due to excessive speed. (bloomberg.com)
- Hands-free driving systems still require driver vigilance. (wsj.com)
- The luxury automakers moving away from leather seats. (arstechnica.com)
- How to better negotiate a new car purchase. (wsj.com)
Energy
- How window heat pumps work. (wbur.org)
- Onshore wind and solar are growing in the UK. (carbonbrief.org)
- Solar provider Solv Energy ($MWH) went public this week. (sherwood.news)
- Kevin Kelly and Dan Pink discuss the future of energy with expert Ramez Naam. (bestcasescenarios.transistor.fm)
Environment
- How big an effect will the administration have on emissions? (axios.com)
- The atmosphere is a complicated beast to model. (smithsonianmag.com)
- This company is transforming fishing nets into usable products. (nytimes.com)
- The case for infusing asphalt with plastics. (theconversation.com)
Travel
- This Italian town is sick of tourists. (smithsonianmag.com)
- A cherry blossom festival in Japan was cancelled due to tourists. (theguardian.com)
Technology
- AI doesn’t reduce work. It makes it more intense. (hbr.org)
- How SK Hynix is benefiting from the AI chip boom. (ft.com)
- Today’s smart homes are more trouble than they are worth. (theatlantic.com)
Behavior
- Joy Lere, “Neuroplasticity is the science of hope.” (joylere.substack.com)
- People are asking too much of their dogs. (theconversation.com)
Vaccines
- So much for a better flu vaccine. (scientificamerican.com)
- The FDA’s actions look ‘arbitrary and capricious.’ (marginalrevolution.com)
- It’s a mistake to downplay the risks of even common viruses. (wapo.st)
AI and health
- AI is getting deployed in an already dysfunctional medical system. (nytimes.com)
- AI is getting added to medical devices. The FDA can’t keep up. (reuters.com)
Fertility
- The opportunity cost for women of having children has risen over time. (ft.com)
- A simple model of fertility decline. (marginalrevolution.com)
Health
- There is an important distinction between medicine and public health. (theatlantic.com)
- Late-in-life depression may presage other maladies. (sciencedaily.com)
- Doctors can’t agree on how to diagnose Alzheimer’s disease. (wsj.com)
- How hearing aids seem to help stave off dementia. (sciencedaily.com)
Drink
- On the lost art of sharing a bottle of wine. (wineenthusiast.com)
- French alcohol exports continue to fall. (sherwood.news)
Food
- The modern food system is a miracle. We just need to make sure it works better. (nytimes.com)
- Dollar Tree ($DLTR) is moving into wealthier areas. (wenatcheeworld.com)
- How Peru became a blueberry export powerhouse. (sftw.substack.com)
Sports
- The NFL still hasn’t come clean on CTE. (statnews.com)
- Stephen Dubner on the claims that cannabis is a performance-enhancing drug for athletes. (freakonomics.com)
- Two professional volleyball leagues are fighting for dominance. (nytimes.com)
College
- Ann Garcia, “College doesn’t just replace one set of expenses with tuition—it reshuffles your entire household budget.” (thecollegefinanciallady.com)
- How to appeal financial aid rewards. (wealthmanagement.com)
Earlier on Abnormal Returns
- Podcast links: betting on AI. (abnormalreturns.com)
- What you missed in our Thursday linkfest. (abnormalreturns.com)
- Don’t miss a thing! Sign up for our daily e-mail newsletter. (abnormalreturns.com)
Mixed media
Terms and Conditions
This content, which contains security-related opinions and/or information, is provided for informational purposes only and should not be relied upon in any manner as professional advice, or an endorsement of any practices, products or services. There can be no guarantees or assurances that the views expressed here will be applicable for any particular facts or circumstances, and should not be relied upon in any manner. You should consult your own advisers as to legal, business, tax, and other related matters concerning any investment.
The commentary in this “post” (including any related blog, podcasts, videos, and social media) reflects the personal opinions, viewpoints, and analyses of the Ritholtz Wealth Management employees providing such comments, and should not be regarded the views of Ritholtz Wealth Management LLC. or its respective affiliates or as a description of advisory services provided by Ritholtz Wealth Management or performance returns of any Ritholtz Wealth Management Investments client.
References to any securities or digital assets, or performance data, are for illustrative purposes only and do not constitute an investment recommendation or offer to provide investment advisory services. Charts and graphs provided within are for informational purposes solely and should not be relied upon when making any investment decision. Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others.
Please see disclosures here.
